Astal Laboratories Ltd
Astal Laboratories Ltd (ASTALLTD) last traded at ₹83, a market capitalisation of ₹364 crore, on a P/E of 24.7. Over the past 52 weeks the stock has ranged between ₹60.4 and ₹103. Astal Laboratories Ltd last reported results for the quarter ended Jun 2026, with sales of ₹101 crore and net profit of ₹9.42 crore. Figures are as of 25 Aug 2026 and are not real time.
Astal Laboratories Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Astal Laboratories Ltd quarterly results
| ₹ crore | Mar 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Sales | 23.47 | 52.24 | 134 | 101 |
| Expenses | 19.29 | 48.69 | 124 | 88.69 |
| Operating profit | 4.18 | 3.55 | 10.19 | 12.25 |
| OPM % | 17.81% | 6.80% | 7.60% | 12.14% |
| Other income | 0.04 | 0.04 | 0.1 | 0.14 |
| Interest | 0.27 | 0.33 | 1.09 | 1.18 |
| Depreciation | 0.1 | 0.12 | 0.86 | 0.86 |
| Profit before tax | 3.85 | 3.14 | 8.34 | 10.35 |
| Tax % | 28.57% | 24.52% | 7.91% | 8.99% |
| Net profit | 2.74 | 2.36 | 7.68 | 9.42 |
| EPS (₹) | 2.79 | 2.19 | 1.82 | 2.15 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Astal Laboratories Ltd annual results
| ₹ crore | Mar 2025 | Mar 2026 |
|---|---|---|
| Sales | 64 | 249 |
| Operating profit | 13 | 21 |
| OPM % | 20% | 8% |
| Net profit | 9 | 15 |
| EPS (₹) | 9.08 | 3.48 |
TTM is the trailing twelve months to the most recent quarter.
Astal Laboratories Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 288%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 65%
- 10 Years
- 14%
- 5 Years
- 51%
- 3 Years
- 45%
- 1 Year
- 2%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- Last Year
- 8%
Astal Laboratories Ltd shareholding pattern
Promoters held 4.53% at Jun 2026, down from 19.93% at Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 19.93% | 19.93% | 19.93% | 19.93% | 18.19% | 18.19% | 4.70% | 4.53% |
| Public | 80.07% | 80.07% | 80.07% | 80.08% | 81.81% | 81.79% | 95.29% | 95.46% |
| No. of shareholders | 1,629 | 1,925 | 2,302 | 2,721 | 2,899 | 2,926 | 3,065 | 3,274 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Astal Laboratories Ltd corporate filings
- Submission of Newspaper publication of financial results for the quarter ended 30th June, 2026.Company Updatehigh impact
Cruxal's analysis: Astal Laboratories Limited has released its unaudited standalone and consolidated…
Read the full analysis - Submission of Statement of Deviation & VariationCompany Updatelow impact
Cruxal's analysis: Astal Laboratories Ltd has filed a Statement of Deviation or Variation regarding the…
Read the full analysis - Submission of Financial Results for the quarter ended June 30, 2026.Resulthigh impact
Cruxal's analysis: Astal Laboratories Limited has declared its unaudited financial results for the quarter…
Read the full analysis - Submission of Outcome of Board Meeting.Board Meetinghigh impact
Cruxal's analysis: Astal Laboratories Limited has announced its unaudited financial results for the quarter…
Read the full analysis - Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Prior intimation of Board ....Board Meetinglow impact
Cruxal's analysis: Astal Laboratories Limited has formally intimated the BSE regarding a Board Meeting…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Astal Laboratories Ltd
Cruxal reads every Astal Laboratories Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.